Pyxis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	12.06	9.66	179.29	274.74	8.08	19.69
Short-Term Investments	132.76	109.63	-	-	-	-
Cash & Short-Term Investments	144.82	119.3	179.29	274.74	8.08	19.69
Cash Growth	8.91%	-33.46%	-34.74%	3300.19%	-58.96%	-
Other Receivables	-	0.02	0.6	-	-	-
Receivables	-	0.02	0.6	-	-	-
Prepaid Expenses	2.58	1.01	1.31	1.76	0.01	0.01
Restricted Cash	1.47	1.47	1.47	1.47	-	-
Other Current Assets	-	2.8	3.94	0.7	0.02	-
Total Current Assets	148.87	124.6	186.61	278.67	8.1	19.7
Property, Plant & Equipment	22.82	24.81	24.77	1.24	1.94	0.08
Other Intangible Assets	23.62	24.31	-	-	-	-
Other Long-Term Assets	-	-	-	0.11	0.11	0.03
Total Assets	195.31	173.73	211.38	280.02	10.15	19.81
Accounts Payable	4.87	3.9	7.1	11.95	1.08	0.49
Accrued Expenses	14.06	12.62	23.45	6.33	1.88	0.12
Current Portion of Leases	1.39	1.23	-	0.17	0.62	0.01
Current Income Taxes Payable	-	-	-	-	-	0.11
Current Unearned Revenue	-	7.66	-	-	-	-
Other Current Liabilities	-	0.36	1.09	0.27	0.12	-
Total Current Liabilities	20.32	25.76	31.63	18.71	3.69	0.73
Long-Term Leases	19.15	20.1	18.92	-	0.17	0.01
Long-Term Deferred Tax Liabilities	2.16	2.16	-	-	-	-
Total Liabilities	41.63	48.02	50.56	18.71	3.85	0.74
Common Stock	0.06	0.05	0.03	0.03	0	0.01
Additional Paid-In Capital	481.26	411.82	373.23	353	0.1	0.04
Retained Earnings	-327.99	-286.23	-212.44	-91.72	-15.74	-2.92
Comprehensive Income & Other	0.35	0.06	-	-	-	-
Total Common Equity	153.68	125.7	160.82	261.31	-15.65	-2.87
Shareholders' Equity	153.68	125.7	160.82	261.31	6.3	19.07
Total Liabilities & Equity	195.31	173.73	211.38	280.02	10.15	19.81
Total Debt	20.54	21.33	18.92	0.17	0.78	0.02
Net Cash (Debt)	124.28	97.97	160.37	274.57	7.3	19.68
Net Cash Growth	11.61%	-38.91%	-41.59%	3661.23%	-62.90%	-
Net Cash Per Share	2.29	2.46	4.85	32.33	7.08	29.29
Filing Date Shares Outstanding	59.47	58.13	36.83	32.22	1.29	0.67
Total Common Shares Outstanding	59.45	44.75	34.96	32.17	1.29	0.67
Working Capital	128.55	98.85	154.98	259.97	4.41	18.97
Book Value Per Share	2.59	2.81	4.60	8.12	-12.13	-4.28
Tangible Book Value	130.06	101.4	160.82	261.31	-15.65	-2.87
Tangible Book Value Per Share	2.19	2.27	4.60	8.12	-12.13	-4.28
Machinery	-	4.52	3.28	1.9	1.36	0.06
Construction In Progress	-	-	9.18	-	-	-
Leasehold Improvements	-	10.96	0.53	0.23	0.21	-

Source: S&P Capital IQ. Standard template. Financial Sources.